Biocon Ltd.

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
22-Oct-18 Motilal Oswal Positive Committee opinion Neutral 658 625 -5.02
24-Sep-18 Motilal Oswal Favorable regulatory outcome enhances biosimilars prospects Buy 665 625 -6.02
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612
3-Dec-17 Motilal Oswal Mylan/ Biocon received Trastuzumab approval in US Neutral 447 485 8.5
27-Oct-17 Nirmal Bang Sec Slowdown In Biosimilar Business As Well As Licensing Income Sell 360 308 -14.44

Upcoming Events and Recent Updates

Download 16-Oct-20
Management Interview - Kiran Mazumdar Shaw,CMD - Economics Of A Pandemic With Kiran Mazumdar-Shaw At Bloomberg India Economic Forum 2020  ( updated on Oct 16 2020)

Analyst Calls / Meets


Management Interviews

16-Oct-20 Kiran Mazumdar ..  
09-Sep-20 Kiran Mazumdar ..  
24-Jul-20 Kiran Mazumdar ..  
13-Jul-20 Kiran Mazumdar ..  
08-Jul-20 Kiran Mazumdar ..  

Investor Presentations


Annual Reports
Source: Reportjunction.com

2019-20  
2018-19  
2017-18  
2016-17  
2015-16  

Research Showcase

22-Oct-18
Motilal Oswal -..
Download
24-Sep-18
Motilal Oswal -..
Download
11-Apr-18
SPA Securities ..
Download
03-Dec-17
Motilal Oswal -..
Download
27-Oct-17
Nirmal Bang Sec..
Download

Results

23-Jul-20 Results
14-May-20 Results
28-Apr-20 Results
24-Jan-20 Results
11-Dec-19 Results

AGM/EGM/Board Meetings

24-Jul-20 - AGM
23-Jul-20 - Quarterly Results
14-May-20 - Audited Results
23-Jan-20 - Quarterly Results
26-Jul-19 - AGM

Press Release

23-Sep-20 Press Release
24-Jul-20 Press Release
11-Jul-20 Press Release
05-Jun-20 Press Release
01-Jun-20 Press Release

 

Archived Documents

No Archieved Transcript.